Parallax Volatility Advisers
CLVS

Parallax Volatility Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Parallax Volatility Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-220,000
Closed -$865K – 2731
2019
Q3 		$865K Buy
+220,000
New +$1.78M ﹤0.01% 1439
2017
Q3 		– Sell
-27,000
Closed -$2.53M – 3564
2017
Q2 		$2.53M Buy
+27,000
New +$1.65M ﹤0.01% 763
2016
Q4 		– Sell
-14,700
Closed -$530K – 4425
2016
Q3 		$530K Buy
+14,700
New +$315K ﹤0.01% 1482
2016
Q1 		– Sell
-1,000
Closed -$35K – 3973
2015
Q4 		$35K Buy
+1,000
New +$64.5K ﹤0.01% 2434

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Parallax Volatility Advisers's CLVS Position: Q2 2022 in Review

Parallax Volatility Advisers sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 86,340 shares — an estimated $174K sold.

Parallax Volatility Advisers first reported a position in CLVS in Q4 2015 and held it in 10 quarters. The position peaked at $1.99M in Q3 2017. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Parallax Volatility Advisers reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 86,340 Clovis Oncology, Inc. shares in Q2 2022, an estimated $174K.
  • Parallax Volatility Advisers first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 10 quarters.
  • Parallax Volatility Advisers's Clovis Oncology, Inc. position peaked at $1.99M in Q3 2017.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Parallax Volatility Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.